Advertisement
HIND vs MTNB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIND is a Hold and MTNB is a Hold.
HIND saw its Stochastic Oscillator peaks and leaves the overbought zone
The Stochastic Oscillator for HIND moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 19 similar instances where the indicator exited the overbought zone. In 18 of the 19 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIND as a result. In 84 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HIND turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 38 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIND declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HIND entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIND's RSI Oscillator exited the oversold zone, 38 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
Following a +3.00% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIND advanced for three days, in 142 of 174 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
HIND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.356) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (108.696) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. HIND’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIND’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
MTNB in -3.20% downward trend, sliding for three consecutive days on October 15, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MTNB declined for three days, in 305 of 331 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
MTNB broke above its upper Bollinger Band on October 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on MTNB as a result. In 69 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 73%.
Following a +3.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTNB advanced for three days, in 160 of 203 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 87 of 107 cases where MTNB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 81%.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.377) is normal, around the industry mean (26.782). P/E Ratio (0.000) is within average values for comparable stocks, (43.395). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (0.000) among similar stocks. P/S Ratio (34.843) is also within normal values, averaging (437.542).
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. MTNB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTNB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
HIND | MTNB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 40 Fair valued | 24 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 99 | |
PRICE GROWTH RATING 1..100 | 77 | 92 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MTNB's Valuation (24) in the Biotechnology industry is in the same range as HIND (40) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.
MTNB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.
MTNB's SMR Rating (99) in the Biotechnology industry is in the same range as HIND (100) in the null industry. This means that MTNB’s stock grew similarly to HIND’s over the last 12 months.
HIND's Price Growth Rating (77) in the null industry is in the same range as MTNB (92) in the Biotechnology industry. This means that HIND’s stock grew similarly to MTNB’s over the last 12 months.
HIND's P/E Growth Rating (100) in the null industry is in the same range as MTNB (100) in the Biotechnology industry. This means that HIND’s stock grew similarly to MTNB’s over the last 12 months.
| HIND | MTNB | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 86% | N/A |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 83% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 73% |
| MACD ODDS (%) | 2 days ago 86% | N/A |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 81% |
| Advances ODDS (%) | 8 days ago 82% | 8 days ago 79% |
| Declines ODDS (%) | 3 days ago 90% | 2 days ago 90% |
| BollingerBands ODDS (%) | 2 days ago 83% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 81% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HIND’s FA Score shows that 0 FA rating(s) are green while MTNB’s FA Score has 1 green FA rating(s).
- HIND’s FA Score: 0 green, 5 red.
- MTNB’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HIND’s TA Score shows that 3 TA indicator(s) are bullish while MTNB’s TA Score has 4 bullish TA indicator(s).
- HIND’s TA Score: 3 bullish, 5 bearish.
- MTNB’s TA Score: 4 bullish, 2 bearish.
Price Growth
HIND (@Biotechnology) experienced а -5.47% price change this week, while MTNB (@Biotechnology) price change was -14.49% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.28%. For the same industry, the average monthly price growth was -17.87%, and the average quarterly price growth was -21.14%.
Reported Earning Dates
HIND is expected to report earnings on Nov 24, 2026.
Industries' Descriptions
@Biotechnology (-10.28% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
HIND and
Correlation & Price change
A.I.dvisor indicates that over the last year, HIND has been loosely correlated with IMMP. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if HIND jumps, then IMMP could also see price increases.
| Ticker / NAME | Correlation To HIND | 1D Price Change % | ||
|---|---|---|---|---|
| HIND | 100% | N/A | ||
| IMMP - HIND | 36% Loosely correlated | -5.03% | ||
| GUTS - HIND | 33% Loosely correlated | +1.96% | ||
| CABA - HIND | 31% Poorly correlated | -4.32% | ||
| CLDX - HIND | 31% Poorly correlated | +3.93% | ||
| PHAT - HIND | 30% Poorly correlated | +1.35% | ||
More | ||||
MTNB and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with SPRC. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then SPRC could also see price increases.
| Ticker / NAME | Correlation To MTNB | 1D Price Change % | ||
|---|---|---|---|---|
| MTNB | 100% | -2.42% | ||
| SPRC - MTNB | 35% Loosely correlated | -45.65% | ||
| AXON - MTNB | 34% Loosely correlated | +2.15% | ||
| VKTX - MTNB | 32% Poorly correlated | +7.46% | ||
| MDGL - MTNB | 31% Poorly correlated | -0.04% | ||
| DCOY - MTNB | 29% Poorly correlated | +5.13% | ||
More | ||||